A192820 Stock Overview
Cosmax, Inc. researches, develops, produces, and manufactures cosmetic and health function food products in Korea and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 4/6 |
| Past Performance | 5/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Cosmax, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩130,600.00 |
| 52 Week High | ₩157,200.00 |
| 52 Week Low | ₩71,000.00 |
| Beta | 0.63 |
| 1 Month Change | 12.10% |
| 3 Month Change | 1.08% |
| 1 Year Change | 77.20% |
| 3 Year Change | 17.13% |
| 5 Year Change | -5.70% |
| Change since IPO | 94.35% |
Recent News & Updates
We Like These Underlying Return On Capital Trends At Cosmax (KRX:192820)
Apr 18
Statutory Profit Doesn't Reflect How Good Cosmax's (KRX:192820) Earnings Are
Mar 27Cosmax, Inc.'s (KRX:192820) Share Price Matching Investor Opinion
Mar 20We Think Cosmax (KRX:192820) Is Taking Some Risk With Its Debt
Feb 29Recent updates
We Like These Underlying Return On Capital Trends At Cosmax (KRX:192820)
Apr 18Statutory Profit Doesn't Reflect How Good Cosmax's (KRX:192820) Earnings Are
Mar 27Cosmax, Inc.'s (KRX:192820) Share Price Matching Investor Opinion
Mar 20We Think Cosmax (KRX:192820) Is Taking Some Risk With Its Debt
Feb 29Does Cosmax (KRX:192820) Have A Healthy Balance Sheet?
Apr 16Investors Can Find Comfort In Cosmax's (KRX:192820) Earnings Quality
Mar 25Will Cosmax (KRX:192820) Multiply In Value Going Forward?
Mar 10What Type Of Shareholders Make Up Cosmax, Inc.'s (KRX:192820) Share Registry?
Feb 23Is It Worth Buying Cosmax, Inc. (KRX:192820) For Its 0.8% Dividend Yield?
Feb 08
Cosmax (KRX:192820) Share Prices Have Dropped 41% In The Last Five Years
Jan 22Boasting A 6.1% Return On Equity, Is Cosmax, Inc. (KRX:192820) A Top Quality Stock?
Jan 07There's A Lot To Like About Cosmax's (KRX:192820) Upcoming ₩900 Dividend
Dec 25Here's Why Cosmax (KRX:192820) Has A Meaningful Debt Burden
Dec 14We're Watching These Trends At Cosmax (KRX:192820)
Dec 01Shareholder Returns
| A192820 | KR Personal Products | KR Market | |
|---|---|---|---|
| 7D | -0.9% | 4.0% | 0.5% |
| 1Y | 77.2% | -2.4% | 4.7% |
Return vs Industry: A192820 exceeded the KR Personal Products industry which returned -2.4% over the past year.
Return vs Market: A192820 exceeded the KR Market which returned 4.7% over the past year.
Price Volatility
| A192820 volatility | |
|---|---|
| A192820 Average Weekly Movement | 5.5% |
| Personal Products Industry Average Movement | 5.2% |
| Market Average Movement | 5.3% |
| 10% most volatile stocks in KR Market | 11.8% |
| 10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A192820 has not had significant price volatility in the past 3 months.
Volatility Over Time: A192820's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | 1,201 | Jaecheon Kim | www.cosmax.com |
Cosmax, Inc. researches, develops, produces, and manufactures cosmetic and health function food products in Korea and internationally. The company operates through Cosmetic Business segment, Custom Cosmetic, and other Business segments. The company offers skincare products under the Capsule+, IS-LCE, CeraPresso, Emulixir, Foamology, IRPT, and Solar Clear brands; base-make up under the Air Cloud, and skin fabric names; and make up under the Xfine, JellTeX, ARTCOTTA, Bi-Coat, creamline, Thixolash, and CRYSTAL PRISM brands; oriental medicine under the Ginsenology name; and fragrance under the Scenteritage brand, as well as hair care products.
Cosmax, Inc. Fundamentals Summary
| A192820 fundamental statistics | |
|---|---|
| Market cap | ₩1.48t |
| Earnings (TTM) | ₩57.14b |
| Revenue (TTM) | ₩1.78t |
25.9x
P/E Ratio0.8x
P/S RatioIs A192820 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A192820 income statement (TTM) | |
|---|---|
| Revenue | ₩1.78t |
| Cost of Revenue | ₩1.48t |
| Gross Profit | ₩293.00b |
| Other Expenses | ₩235.86b |
| Earnings | ₩57.14b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 5.04k |
| Gross Margin | 16.48% |
| Net Profit Margin | 3.21% |
| Debt/Equity Ratio | 168.0% |
How did A192820 perform over the long term?
See historical performance and comparison